Spectrum Pharmaceuticals


FDA OK’s Spectrum Cancer Drug for Wider Use

Spectrum Pharmaceuticals

An Irvine drug maker, Spectrum Pharmaceuticals Inc., has said that it got regulatory approval for an expanded use of a cancer drug.

Spectrum said that the FDA approved Zevalin as an early treatment for a blood cancer, in patients with non-Hodgkin's lymphoma. The drug was used previously on patients whose tumors did not respond to other treatments.

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics Spectrum Pharmaceuticals and Cell Therapeutics have entered into an agreement to form a 50:50 owned joint venture, RIT Oncology, to commercialize and develop Zevalin in the United States.

Latest News

Fathom Cruise Brand’s Adonia Continues its Journey to Cuba after “Electrical Dif
Oil Prices Rise in the U.S Right at the Beginning of the Summer Driving Season w
With Increase in Exports the Australian Dollar Gains the Most in Four Weeks
Viacom Board of Directors Stick Together to Fight Redstone Family’s Effort to Ej
Worshipers lose church after decades of fight
Criticism after rare gorilla is killed to save child in Cincinnati Zoo
Noble Group Announced Its Chief Executive Yusuf Alireza is Resigning due to “Fam
Puerto Rico Gets Some Relief with Rescue Bill and Demand and Improving Agricultu
PageProof Learnt from the U.S Market, Language is Important!
James Bullard St. Louis Federal Reserve President says Global Markets Appear to
Memorial Day Sales Kicks Off with Retailers Offering Big Discounts
Coca Cola to Roll Out Limited Edition “Proud to be an American’ Cans this Weeken
Syndicate content